Showing results (1201-1210 of 10,440) with videos related to
Sort By:
Pageof 1,044
AIDS (London, England)|April 18, 2023
Immunogenicity, effectiveness, and safety of SARS-CoV-2 vaccination in people with HIVDavid W J Griffin, Rekha Pai Mangalore, Jennifer F Hoy, et al.AIDS (London, England)|April 18, 2023
Experiencing homelessness and progression through the HIV cascade of care among people who use drugsHudson Reddon, Nadia Fairbairn, Cameron Grant, et al.AIDS (London, England)|April 8, 2015
Human papilloma virus vaccination induces strong human papilloma virus specific cell-mediated immune responses in HIV-infected adolescents and young adultsVeronica Rainone, Vania Giacomet, Francesca Penagini, et al.AIDS (London, England)|December 1, 1989
Pilot phase I study using zidovudine in association with a 10-day course of anti-CD4 monoclonal antibody in seven AIDS patientsC Dhiver, D Olive, S Rousseau, et al.AIDS (London, England)|December 1, 1989
Lack of activity of zidovudine in AIDS-associated Kaposi's sarcomaR de Wit, P Reiss, P J Bakker, et al.AIDS (London, England)|December 1, 1989
An open study of interferon in HIV-antibody-positive menM E Ellis, M R Haeney, J Craske, et al.AIDS (London, England)|March 14, 2015
Time above 1500 copies: a viral load measure for assessing transmission risk of HIV-positive patients in careGary Marks, Lytt I Gardner, Charles E Rose, et al.AIDS (London, England)|June 1, 1989
Advanced immunodeficiency as a risk factor for heterosexual transmission of HIVM Laga, H Taelman, P Van der Stuyft, et al.AIDS (London, England)|September 1, 1989
Appearance of predictors of disease progression in relation to the development of AIDSF de Wolf, J M Lange, J T Houweling, et al.AIDS (London, England)|February 25, 2015
Pubertal development in HIV-infected African children on first-line antiretroviral therapyAlexander J Szubert, Victor Musiime, Mutsawashe Bwakura-Dangarembizi, et al.Pageof 1,044